Fig. 4From: Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization studyCausal effects of MAFLD on the levels of amino acids. Four SNPs, rs3747207 (PNPLA3), rs429358 (APOE), rs73001065 (TM6SF2) and rs28601761 (TRIB1), were used as instrumental variables for MAFLD to infer the causal effects of genetically predicted MAFLD on the levels of amino acids. APOE, apolipoprotein E; PNPLA3, Patatin-like phospholipase domain containing 3; TM6SF2, transmembrane 6 superfamily member 2; TRIB1, Tribbles pseudokinase 1; MAFLD, metabolic dysfunction-associated fatty liver disease; SD, standard deviationBack to article page